MIT researchers have developed a revolutionary machine learning framework for drug development and material science, predicting molecular properties and generating new molecules with limited training data.
Discover how AI is transforming the pharmaceutical industry, from mundane tasks to drug development. Eli Lilly CEO David Ricks reveals the potential of AI.
Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?